Biotech stocks are in a post-pandemic slump and recovery in 2024 is questionable
October 20, 2023 at 07:10 AM EDT
Once buoyed by demand for COVID-19 vaccines and treatments, the biotech industry is experiencing a sobering leveling out
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|